Elevation Oncology Ownership | Who Owns Elevation Oncology?

Elevation Oncology Ownership Summary

Elevation Oncology is owned by 57.49% institutional investors, 0.27% insiders, and 42.25% retail investors. Tang capital management is the largest institutional shareholder, holding 8.05% of ELEV shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.76% of its assets in Elevation Oncology shares.

ELEV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Elevation Oncology	57.49%	0.27%	42.25%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	4.76M	8.05%	$2.68M
Farallon capital management	3.53M	5.97%	$1.98M
Blackrock funding, inc. /de	3.16M	5.35%	$1.78M
Bvf inc/il	2.97M	5.02%	$1.67M
Frazier life sciences management	2.96M	5.01%	$7.99M
Aisling capital management lp	2.83M	4.80%	$1.59M
Vanguard group	2.61M	4.42%	$1.47M
Blackrock	2.49M	4.22%	$6.72M
Goldman sachs group	1.65M	2.79%	$929.26K
Renaissance	1.60M	2.71%	$902.02K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aisling capital management lp	2.83M	0.56%	$1.59M
Frazier life sciences management	2.96M	0.37%	$7.99M
Allostery investments lp	432.21K	0.25%	$243.16K
Tang capital management	4.76M	0.18%	$2.68M
Sphera funds management	1.02M	0.10%	$573.04K
Stonepine capital management	200.00K	0.09%	$112.52K
Artal group	1.01M	0.07%	$2.74M
Bvf inc/il	2.97M	0.06%	$1.67M
Ikarian capital	690.05K	0.05%	$388.22K
Velan capital investment management lp	45.00K	0.02%	$25.32K

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	2.96M	0.37%	2.96M
Blackrock	2.49M	0.00%	2.32M
Morgan stanley	1.27M	0.00%	1.25M
Allostery investments lp	432.21K	0.25%	432.21K
Blackrock funding, inc. /de	3.16M	-	258.01K

Top Sellers

Holder	Shares	% Assets	Change
Logos global management lp	-	-	-3.85M
Balyasny asset management	-	-	-2.48M
Venbio partners	-	-	-2.43M
Goldman sachs group	1.65M	0.00%	-2.34M
Darwin global management	-	-	-1.92M

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	2.96M	0.37%	2.96M	$7.99M
Allostery investments lp	432.21K	0.25%	432.21K	$243.16K
Stonepine capital management	200.00K	0.09%	200.00K	$112.52K
Wellington management group llp	116.07K	0.00%	116.07K	$313.38K
Virtu financial	63.97K	0.00%	63.97K	$36.00K

Sold Out

Holder	Change
Capital performance advisors llp	-11.00
Macquarie group	-1.27K
Mercer global advisors inc /adv	-10.03K
Ctc alternative strategies	-11.10K
Prelude capital management	-12.24K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	71	2.90%	33,979,478	-26.03%	57	0.95%	39	-	13	-23.53%
Sep 30, 2024	69	-14.81%	45,936,801	-11.86%	77	1.00%	39	-25.00%	17	-19.05%
Jun 30, 2024	81	26.56%	52,117,516	18.46%	88	1.02%	52	1.96%	21	133.33%
Mar 31, 2024	64	106.45%	43,997,469	70.21%	92	2.50%	51	628.57%	9	28.57%
Dec 31, 2023	31	-22.50%	25,848,863	-7.84%	60	1.39%	7	-65.00%	7	16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.64M	2.76%	-
iShares Russell 2000 ETF	1.34M	2.27%	-11.61K
Vanguard Institutional Extnd Mkt Idx Tr	608.57K	1.03%	-
Fidelity Small Cap Index	536.45K	0.91%	-10.05K
Aesculape SRI IC	507.00K	0.86%	-
iShares Russell 2000 Growth ETF	472.06K	0.80%	-2.24K
Vanguard US Momentum Factor ETF	430.42K	0.73%	430.42K
State St Russell Sm/Mid Cp® Indx NL Cl C	300.71K	0.51%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	300.71K	0.51%	-
Fidelity Extended Market Index	284.01K	0.48%	-1.81K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 25, 2022	venBio Global Strategic Fund III, L.P.	-	Sell	$2.90M
May 25, 2022	Royston Aaron		Sell	$2.90M
Jun 29, 2021	Qiming U.S. Healthcare Fund II, L.P.	-	Buy	$5.00M
Jun 29, 2021	Aisling Capital IV, LP	-	Buy	$3.00M
Jun 29, 2021	venBio Global Strategic Fund III, L.P.	-	Buy	$10.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

ELEV Ownership FAQ

Who Owns Elevation Oncology?

Elevation Oncology shareholders are primarily institutional investors at 57.49%, followed by 0.27% insiders and 42.24% retail investors. The average institutional ownership in Elevation Oncology's industry, Biotech Stocks , is 68.48%, which Elevation Oncology falls below.

Who owns the most shares of Elevation Oncology?

Elevation Oncology’s largest shareholders are Tang capital management (4.76M shares, 8.05%), Farallon capital management (3.53M shares, 5.97%), and Blackrock funding, inc. /de (3.16M shares, 5.35%). Together, they hold 19.37% of Elevation Oncology’s total shares outstanding.

Does Blackrock own Elevation Oncology?

Yes, BlackRock owns 4.22% of Elevation Oncology, totaling 2.49M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.72M$. In the last quarter, BlackRock increased its holdings by 2.32M shares, a 1348.65% change.

Who is Elevation Oncology’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is Elevation Oncology’s biggest shareholder by percentage of total assets invested, with 0.56% of its assets in 2.83M Elevation Oncology shares, valued at 1.59M$.

Who is the top mutual fund holder of Elevation Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elevation Oncology shares, with 2.76% of its total shares outstanding invested in 1.64M Elevation Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools